FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2017675037> ?p ?o ?g. }

• W2017675037 abstract "Seventy percent of all bladder tumours tend to recur and need intensive surveillance, and a subset of tumours progress to muscle-invasive and metastatic disease. However, it is still difficult to find the adequate treatment for every individual patient as it is a very heterogeneous disease and reliable biomarkers are still missing. In our study we searched for new target genes in the critical chromosomal region 8p and investigated the potential tumour suppressor gene candidate MTUS1/ATIP in bladder cancer. MTUS1 was identified to be the most promising deleted target gene at 8p in aCGH analysis with 19 papillary bladder tumours. A correlation with bladder cancer was further validated using immunohistochemistry of 85 papillary and 236 advanced bladder tumours and in functional experiments. Kaplan-Meier analysis and multivariate Cox-regression addressed overall survival (OS) and disease-specific survival (DSS) as a function of MTUS1/ATIP expression. Bivariate correlations investigated associations between MTUS1/ATIP expression, patient characteristics and histopathology. MTUS1 expression was analysed in cell lines and overexpressed in RT112, where impact on viability, proliferation and migration was measured. MTUS1 protein expression was lost in almost 50% of all papillary and advanced bladder cancers. Survival, however, was only influenced in advanced carcinomas, where loss of MTUS1 was associated with adverse OS and DSS. In this cohort, there was also a significant correlation of MTUS1 expression and histological subtype: positive expression was detected in all micropapillary tumours and aberrant nuclear staining was detected in a subset of plasmocytoid urothelial carcinomas. MTUS1 was expressed in all investigated bladder cell lines and overexpression in RT112 led to significantly decreased viability. MTUS1 is a tumour suppressor gene in cultured bladder cancer cells and in advanced bladder tumours. It might represent one new target gene at chromosome 8p and can be used as an independent prognostic factor for advanced bladder cancer patients. The limitation of the study is the retrospective data analysis. Thus, findings should be validated with a prospective advanced bladder tumour cohort." @default.
• W2017675037 created "2016-06-24" @default.
• W2017675037 creator A5003361991 @default.
• W2017675037 creator A5013320078 @default.
• W2017675037 creator A5016256104 @default.
• W2017675037 creator A5038916177 @default.
• W2017675037 creator A5044131715 @default.
• W2017675037 creator A5044952697 @default.
• W2017675037 creator A5049585448 @default.
• W2017675037 creator A5051529814 @default.
• W2017675037 creator A5051550342 @default.
• W2017675037 creator A5071196966 @default.
• W2017675037 creator A5081907060 @default.
• W2017675037 creator A5088455065 @default.
• W2017675037 creator A5089254227 @default.
• W2017675037 date "2014-03-20" @default.
• W2017675037 modified "2023-09-23" @default.
• W2017675037 title "Loss of MTUS1/ATIP expression is associated with adverse outcome in advanced bladder carcinomas: data from a retrospective study" @default.
• W2017675037 cites W1544580766 @default.
• W2017675037 cites W1862973715 @default.
• W2017675037 cites W1964568317 @default.
• W2017675037 cites W1972504105 @default.
• W2017675037 cites W1974816540 @default.
• W2017675037 cites W1976770439 @default.
• W2017675037 cites W1979349275 @default.
• W2017675037 cites W1991461625 @default.
• W2017675037 cites W1995801607 @default.
• W2017675037 cites W2024487267 @default.
• W2017675037 cites W2028162037 @default.
• W2017675037 cites W2049299149 @default.
• W2017675037 cites W2052987836 @default.
• W2017675037 cites W2057989030 @default.
• W2017675037 cites W2064784860 @default.
• W2017675037 cites W2067973442 @default.
• W2017675037 cites W2084449343 @default.
• W2017675037 cites W2086831568 @default.
• W2017675037 cites W2092338124 @default.
• W2017675037 cites W2097671131 @default.
• W2017675037 cites W2100732823 @default.
• W2017675037 cites W2113318017 @default.
• W2017675037 cites W2114570899 @default.
• W2017675037 cites W2136117114 @default.
• W2017675037 cites W2139626318 @default.
• W2017675037 cites W2150587253 @default.
• W2017675037 cites W2152418443 @default.
• W2017675037 cites W2162813066 @default.
• W2017675037 cites W2165119870 @default.
• W2017675037 cites W4255137433 @default.
• W2017675037 cites W2031650995 @default.
• W2017675037 doi "https://doi.org/10.1186/1471-2407-14-214" @default.
• W2017675037 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3994487" @default.
• W2017675037 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24650297" @default.
• W2017675037 hasPublicationYear "2014" @default.
• W2017675037 type Work @default.
• W2017675037 sameAs 2017675037 @default.
• W2017675037 citedByCount "16" @default.
• W2017675037 countsByYear W20176750372015 @default.
• W2017675037 countsByYear W20176750372016 @default.
• W2017675037 countsByYear W20176750372017 @default.
• W2017675037 countsByYear W20176750372018 @default.
• W2017675037 countsByYear W20176750372019 @default.
• W2017675037 countsByYear W20176750372020 @default.
• W2017675037 countsByYear W20176750372021 @default.
• W2017675037 countsByYear W20176750372023 @default.
• W2017675037 crossrefType "journal-article" @default.
• W2017675037 hasAuthorship W2017675037A5003361991 @default.
• W2017675037 hasAuthorship W2017675037A5013320078 @default.
• W2017675037 hasAuthorship W2017675037A5016256104 @default.
• W2017675037 hasAuthorship W2017675037A5038916177 @default.
• W2017675037 hasAuthorship W2017675037A5044131715 @default.
• W2017675037 hasAuthorship W2017675037A5044952697 @default.
• W2017675037 hasAuthorship W2017675037A5049585448 @default.
• W2017675037 hasAuthorship W2017675037A5051529814 @default.
• W2017675037 hasAuthorship W2017675037A5051550342 @default.
• W2017675037 hasAuthorship W2017675037A5071196966 @default.
• W2017675037 hasAuthorship W2017675037A5081907060 @default.
• W2017675037 hasAuthorship W2017675037A5088455065 @default.
• W2017675037 hasAuthorship W2017675037A5089254227 @default.
• W2017675037 hasBestOaLocation W20176750371 @default.
• W2017675037 hasConcept C121608353 @default.
• W2017675037 hasConcept C126322002 @default.
• W2017675037 hasConcept C142724271 @default.
• W2017675037 hasConcept C143998085 @default.
• W2017675037 hasConcept C204232928 @default.
• W2017675037 hasConcept C2780140570 @default.
• W2017675037 hasConcept C2780352672 @default.
• W2017675037 hasConcept C502942594 @default.
• W2017675037 hasConcept C50382708 @default.
• W2017675037 hasConcept C71924100 @default.
• W2017675037 hasConceptScore W2017675037C121608353 @default.
• W2017675037 hasConceptScore W2017675037C126322002 @default.
• W2017675037 hasConceptScore W2017675037C142724271 @default.
• W2017675037 hasConceptScore W2017675037C143998085 @default.
• W2017675037 hasConceptScore W2017675037C204232928 @default.
• W2017675037 hasConceptScore W2017675037C2780140570 @default.
• W2017675037 hasConceptScore W2017675037C2780352672 @default.
• W2017675037 hasConceptScore W2017675037C502942594 @default.
• W2017675037 hasConceptScore W2017675037C50382708 @default.
• W2017675037 hasConceptScore W2017675037C71924100 @default.
• W2017675037 hasIssue "1" @default.

• next